Search
for
Sort by
Research 181–210 of 786
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Emerging treatments in alopecia
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Baricitinib for the Treatment of Alopecia Areata
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- New and Emerging Therapies for Alopecia Areata
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Mechanisms of autophagy and their implications in dermatological disorders
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review